Pall Corp. will acquire the ATMI LifeSciences business of ATMI, Inc. for $185 million. ATMI LifeSciences makes and sells single-use bioprocess systems and consumables for the pharma and biopharma industries. The deal is expected to close by the end of Pall’s third quarter, which ends in April 2014. For the balance of fiscal 2014, Pall expects the acquisition to add $20 to $30 million in revenue.   “This acquisition immediately strengthens our offering and broadens our already extensive portf...